Upon ligand binding, GLP-1R activation enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite, collectively improving glycemic control and promoting clinically meaningful weight reduction [19]
(2017) Cardiovascular safety and benefits of GLP-1 receptor agonists
Standard cagrilintide dosing follows a 12-week titration from 0.6mg to 2.4mg weekly (0.6mg weeks 1-4, 1.2mg weeks 5-8, 1.8mg weeks 9-12, 2.4mg week 13+)
It leads to a significant increase in postprandial GLP-1 and PYY concentrations in humans and animal models (Jrgensen et al., 2012
The chart below provides complete dosage recommendations organized by your primary goal, including administration method, dose range, frequency, and expected cycle duration